Ameritox now offers test enhancements to detect misuse and abuse of oxymorphone, or Opana. The company's Rx Guardian CD medication monitoring now includes oxymorphone, allowing physicians to compare their patients' levels with a database of patients who were prescribed oxymorphone for chronic pain and were clinically assessed as adherent.
More Articles on Pain Management:
5 Statistics on Chiropractic Use for Medicare Patients
5 Statistics on Anxiety for Pain Patients at EDs
Chronic Pain Management Costs $635B Annually
More Articles on Pain Management:
5 Statistics on Chiropractic Use for Medicare Patients
5 Statistics on Anxiety for Pain Patients at EDs
Chronic Pain Management Costs $635B Annually